VB-111 in Combination With Nivolumab in People With Metastatic Colorectal Cancer (mCRC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
University of California, San Francisco
Sotio Biotech Inc.
Alaunos Therapeutics
Incyte Corporation
Day One Biopharmaceuticals, Inc.
Enterome
NuCana plc
Institut Bergonié
Sotio Biotech Inc.
Hoosier Cancer Research Network
Bristol-Myers Squibb
SafeHeal Inc
University of Florida
Gilead Sciences
Numab Therapeutics AG
Daiichi Sankyo
Hutchmed
Thomas Jefferson University
University of Utah
M.D. Anderson Cancer Center
Elevation Oncology
Boehringer Ingelheim
Georgetown University
Merck Sharp & Dohme LLC
Pfizer
ImmunityBio, Inc.
Highlight Therapeutics
Merck Sharp & Dohme LLC
MEI Pharma, Inc.
AstraZeneca
NantCell, Inc.
Servier
Pfizer
Federation Francophone de Cancerologie Digestive
Wake Forest University Health Sciences
Pfizer
University of Pennsylvania
Kyowa Kirin Co., Ltd.
Pfizer
Eisai Inc.
Georgetown University
Cellestia Biotech AG
Ipsen
Eisai Inc.
Hoffmann-La Roche
Karyopharm Therapeutics Inc
Roswell Park Cancer Institute